Concord Biotech Limited — Investor Meet, 30-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates
30-05-2025 | 06:38 pm
30-05-2025 | 06:38 pm
Concord Biotech discussed the financial results for the quarter and year ended March 31, 2025, focusing on performance highlights and business updates. Management emphasized growth drivers, operational momentum, and future outlook, reinforcing confidence in ongoing strategic priorities. The audio recording is available on the company’s website for detailed insights.
No comments yet. Be the first to comment!
